PRINCIPAL FINANCIAL GROUP INC - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 275 filers reported holding IMMUNOGEN INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.

Quarter-by-quarter ownership
PRINCIPAL FINANCIAL GROUP INC ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$15,626,614
-16.2%
984,664
-0.3%
0.01%
-15.4%
Q2 2023$18,641,404
+8569.5%
987,886
+1664.2%
0.01%
Q1 2023$215,024
-19.4%
55,996
+4.1%
0.00%
Q4 2022$266,763
+7.1%
53,783
+3.1%
0.00%
Q3 2022$249,000
+18.0%
52,167
+11.3%
0.00%
Q2 2022$211,000
-73.0%
46,883
-71.4%
0.00%
Q1 2022$781,000
-52.0%
164,004
-25.2%
0.00%
-100.0%
Q4 2021$1,627,000
+15.3%
219,341
-11.9%
0.00%0.0%
Q3 2021$1,411,000
-15.5%
248,959
-1.7%
0.00%0.0%
Q2 2021$1,670,000
-20.6%
253,289
-2.4%
0.00%0.0%
Q1 2021$2,102,000
+35.4%
259,564
+7.8%
0.00%0.0%
Q4 2020$1,553,000
+53.3%
240,719
-14.5%
0.00%0.0%
Q3 2020$1,013,000
+22.0%
281,497
+56.1%
0.00%0.0%
Q2 2020$830,000
+488.7%
180,299
+334.4%
0.00%
Q1 2020$141,000
-26.9%
41,508
+9.8%
0.00%
Q4 2019$193,000
+93.0%
37,790
-8.4%
0.00%
Q3 2019$100,000
+22.0%
41,262
+10.2%
0.00%
Q2 2019$82,000
-73.5%
37,439
-67.3%
0.00%
Q1 2019$310,000
-43.4%
114,380
+0.2%
0.00%
-100.0%
Q4 2018$548,000
-47.6%
114,173
+3.3%
0.00%0.0%
Q3 2018$1,046,000
+4.2%
110,477
+7.1%
0.00%0.0%
Q2 2018$1,004,000
+9.4%
103,173
+18.3%
0.00%0.0%
Q1 2018$918,000
+86.6%
87,202
+13.6%
0.00%
Q4 2017$492,000
+392.0%
76,762
+488.0%
0.00%
Q3 2017$100,000
-6.5%
13,054
-13.6%
0.00%
Q2 2017$107,000
+84.5%
15,1010.0%0.00%
Q1 2017$58,000
+87.1%
15,1010.0%0.00%
Q4 2016$31,000
-22.5%
15,1010.0%0.00%
Q3 2016$40,000
-14.9%
15,1010.0%0.00%
Q2 2016$47,000
-63.6%
15,1010.0%0.00%
Q1 2016$129,000
-36.5%
15,101
+0.9%
0.00%
Q4 2015$203,000
+45.0%
14,963
+2.6%
0.00%
Q3 2015$140,000
-25.1%
14,581
+12.2%
0.00%
Q2 2015$187,000
+92.8%
12,995
-18.7%
0.00%
Q4 2014$97,000
-48.7%
15,975
-10.6%
0.00%
Q3 2014$189,000
-10.8%
17,8600.0%0.00%
Q2 2014$212,000
-30.5%
17,860
-12.7%
0.00%
-100.0%
Q1 2014$305,000
-28.4%
20,457
-29.6%
0.00%0.0%
Q4 2013$426,000
-14.3%
29,071
-0.5%
0.00%0.0%
Q3 2013$497,000
+54.8%
29,227
+51.2%
0.00%0.0%
Q2 2013$321,00019,3290.00%
Other shareholders
IMMUNOGEN INC shareholders Q3 2023
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 600,000$3,870,0002.25%
CM Management, LLC 375,000$2,419,0002.24%
Consonance Capital Management LP 3,515,944$22,678,0002.12%
RA Capital Management 18,417,458$118,793,0001.66%
Kercheville Advisors, LLC 244,421$1,564,0000.85%
Redmile Group, LLC 10,528,179$67,907,0000.82%
Birchview Capital, LP 190,000$1,226,0000.71%
QVT Financial LP 1,375,900$8,875,0000.49%
Fernwood Investment Management, LLC 149,340$963,0000.38%
TWIN FOCUS CAPITAL PARTNERS, LLC 104,068$671,0000.21%
View complete list of IMMUNOGEN INC shareholders